Skip Nav Destination
Issues
Point/Counterpoint
Hypothesis
Research Articles
Calcium, Vitamin D, and Risk for Colorectal Adenoma: Dependency on Vitamin D Receptor BsmI Polymorphism and Nonsteroidal Anti-Inflammatory Drug Use?1
Sonia M. Boyapati; Roberd M. Bostick; Katherine A. McGlynn; Michael F. Fina; Walter M. Roufail; Kim R. Geisinger; Michael Wargovich; Ann Coker; James R. Hebert
Short Communications
Combination of DNA Repair Gene Single Nucleotide Polymorphisms and Increased Levels of DNA Adducts in a Population-based Study1
Giuseppe Matullo; Marco Peluso; Silvia Polidoro; Simonetta Guarrera; Armelle Munnia; Vittorio Krogh; Giovanna Masala; Franco Berrino; Salvatore Panico; Rosario Tumino; Paolo Vineis; Domenico Palli
Null Results in Brief
Letters to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.